ASX-Dividend-Report-Banner

Jung Kwan Jang Launches a Limited-edition Red Ginseng, Marking its 124th Anniversary

December 28, 2023 10:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Jung Kwan Jang Launches a Limited-edition Red Ginseng, Marking its 124th Anniversary
Image source: Kalkine Media

SEOUL, South Korea, Dec. 28, 2023 /PRNewswire/ -- On December 1, 2023, Jung Kwan Jang honors its 124th anniversary with the unveiling of the Red Ginseng Heritage Edition, a tribute to the company's respect for Korean cultural heritage.

Jung Kwan Jang Red Ginseng Extract Heritage Edition
Jung Kwan Jang Red Ginseng Extract Heritage Edition

Conceived as a "small museum for your own," Red Ginseng Extract Heritage Edition is a limited edition that packages Jung Kwan Jang's signature product, Red Ginseng Extract in six exquisite designs inspired by national treasure-equivalent cultural heritages.

Rooted in shared history and trajectory with Jung Kwan Jang, the beginning Red Ginseng Extract goes back to 1899, the 36th year of King Gojong's reign. The Korean Empire's red ginseng monopoly generated significant revenue for the imperial family, constituting over the half of the family's yearly budget. Adopting a national approach to red ginseng management, the Korean Empire paid attention to the development of processing methods for easier consumption of red ginseng, beyond traditional root forms. As a result, the first processed red ginseng concentrate product like the current Red Ginseng Extract Jung was born in Gaesung, Gyeonggi-do in 1912.

Korea Ginseng Corporation (KGC), Korea's leading health supplement company, is faithfully carrying forth the tradition. KGC is paving a unique way that no one can follow, popularizing and globalizing red ginseng through systematic cultivation management system, rigorous quality assurance, R&D and global market opening.

In particular, it has been contributing to solidifying the country's position as the ginseng pioneer as four functionalities of red ginseng, which are blood circulation improvement, memory improvement, antioxidant activity, and climacteric women health improvement, are recognized as Jung Kwan Jang's technologies, among other benefits accepted by the Korea Ministry of Food and Drug Safety.

KGC R&D Center has published about 290 papers in academic journals in and out of the country, and owns about 200 technical patents and 15 protection rights for its exclusively cultivated species. In 2016, KGC's analysis of ginsenoside received the world's first accreditation from the Korea Laboratory Accreditation Scheme (KOLAS).

Jung Kwan Jang, which has been exporting about 250 products to about 40 countries, has topped the global ginseng retail market in sales for 10 consecutive years, according to global market research institution Euromonitor International. Euromonitor's 2022 report shows the global ginseng retail market was USD2.47 billion last year, with Jung Kwan Jang solidifying its position as the no. 1 ginseng brand with a commanding 41.9% share.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.